Total and free serum prostate specific antigen levels during the first month of acute prostatitis

European Urology

Volumn 43, Issue 6, 2003, Pages 702-705

  Gamé, Xavier ^a,b   Vincendeau, Sébastien ^b   Palascak, Robert ^b   Milcent, Stéphane ^b   Fournier, Robert ^b   Houlgatte, Alain ^b  

^a CHU RANGUEIL   (France)

^b University of Paris Descartes   (France)

Author keywords

Free PSA; Infection; Prostate

Indexed keywords

C REACTIVE PROTEIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; ANAMNESIS; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE HYPERTROPHY; PROSTATITIS; PROTEIN BLOOD LEVEL; SERUM; TIME;

EID: 0038700533     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(03)00158-1     Document Type: Article

References (15)

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979;17:159-63.
2. Tchetgen MN, Oesterling JE. The effect of prostatitis, urinary retention, ejaculation, and ambulation on the serum prostate-specific antigen concentration. Urol Clin N Am 1997;24:283-91.
3. Dalton DL. Elevated serum prostate-specific antigen due to acute bacterial prostatitis. Urology 1989;33:465.
4. Stenmann UH, Leinonen J, Alfthan H, Rannikko S, Thukanen K, Alfthan O. A complex between prostate-specific-antigen and alpha 1 antichymotrypsin is the major form of prostate-specific-antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991;51:222-6.
5. Reissigl A, Klocker H, Pointner J, Ennemoser O, Falk M, Bartsch G. Improvement of prostate cancer screening by determination of the ratio free/total PSA in addition to PSA levels. Prostate 1997;30:243-7.
6. Neal Jr DE, Clejan S, Sarma D, Moon TD. Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate 1992;20:105-11.
7. Jung K, Meyer A, Lein M, Rudolph B, Schnorr D, Loening SA. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate. J Urol 1998;159:1595-8.
8. Scattoni V, Raber M, Montorsi F, Da Pozzo L, Brausi M, Calori G, et al. Percent of free serum prostate-specific-antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia. Eur Urol 1999;36:621-30.
9. Lorente JA, Arango O, Bielsa O, Cortadellas R, Gelabert-Mas A. Effect of antibiotic treatment on serum PSA and percent free PSA levels in patients with biochemical criteria for prostate biopsy and previous lower urinary tract infections. Int J Biol Markers 2002;17:84-9.
10. Ornstein DK, Smith DS, Humprey PA, Catalona WJ. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer. J Urol 1998;159:1234-7.
11. Povoa P, Almeida E, Moreira P, Fernandes A, Mealha R, Aragao A, et al. C-reactive protein as an indicator of sepsis. Intensive Care Med 1998;24:1052-6.
12. Hasui Y, Marutsuka K, Asada Y, Ide H, Nishi S, Osada Y. Relationship between serum prostate-specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 1994;25:91-6.
13. Irani J, Levillain P, Goujon JM, Bon D, Dore B, Aubert J. Inflammation in benign prostatic hyperplasia: correlation with prostate specific antigen value. J Urol 1997;157:1301-3.
14. Breuille D, Voisin L, Contrepois M, Arnal M, Rose F, Obled C. A sustained rat model for studying the long-lasting catabolic state of sepsis. Infect Immun 1999;67:1079-85.
15. Hachulla E, Laine A, Blaringhem T, Canva-Delcambre V, Devulder B, Degand P. Glycoforms of alpha-1 antichymotrypsin in infectious process. Diagnostic value and follow-up. Presse Med 1996;25:661-4.